Stereotaxis Inc. (STXS)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.68+0.02 (+3.03%)
At close: 3:59 PM EDT
People also watch:
HNSNSPNCNUROSTAACRDC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.66
Prev Close0.66
Bid0.00 x
Ask0.00 x
Day's Range0.65 - 0.68
52wk Range0.54 - 2.53
1y Target EstN/A
Market Cap14.86M
P/E Ratio (ttm)-1.99
Beta1.74
Volume58,558
Avg Vol (3m)96,818
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETF’s with exposure to Stereotaxis, Inc. : August 23, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Stereotaxis, Inc. Here are 5 ETF’s with the largest exposure to STXS-US. Comparing the performance and risk of Stereotaxis, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • American City Business Journals13 days ago

    Stereotaxis posts wider loss as system sales plummet

    Stereotaxis, the St. Louis-based maker of medical devices for treating cardiac arrhythmias, reported a net loss of $2.33 million in the second quarter as systems sales dropped about 70 percent (to $935,978) in the quarter compared with the same period last year. Stereotaxis’ total revenue dropped 18.5 percent from $9.66 million in the second quarter of 2015 to $7.87 million in the recent quarter. The number of ventricular tachycardia (VT) procedures — a figure company officials watch closely — increased 24 percent year-over-year, representing the 10th straight quarter of year-over-year volume growth.

  • Stereotaxis, Inc. :STXS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
    Capital Cube14 days ago

    Stereotaxis, Inc. :STXS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016

    Categories: Yahoo Finance Click here to see latest analysis Stereotaxis, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Stereotaxis, Inc. – HeartWare International, Inc., St. Jude Medical, Inc., Dextera Surgical, Inc., Boston Scientific Corporation, Spectranetics Corporation, Edwards Lifesciences Corporation, Johnson & Johnson, Integer Holdings Corporation ... Read more (Read more...)